81 related articles for article (PubMed ID: 32890993)
1. Design, synthesis, biological evaluation, and docking study of novel dual-acting thiazole-pyridiniums inhibiting acetylcholinesterase and β-amyloid aggregation for Alzheimer's disease.
Ghotbi G; Mahdavi M; Najafi Z; Moghadam FH; Hamzeh-Mivehroud M; Davaran S; Dastmalchi S
Bioorg Chem; 2020 Oct; 103():104186. PubMed ID: 32890993
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of edaravone derivatives bearing the
Zondagh LS; Malan SF; Joubert J
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1596-1605. PubMed ID: 32779503
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.
Guo Y; Yang H; Huang Z; Tian S; Li Q; Du C; Chen T; Liu Y; Sun H; Liu Z
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979317
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and molecular docking simulation of new benzimidazole-thiazole hybrids as cholinesterase inhibitors.
Dawood DH; Srour AM; Omar MA; Farghaly TA; El-Shiekh RA
Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300201. PubMed ID: 37937360
[TBL] [Abstract][Full Text] [Related]
6. Development of quinazolinone and vanillin acrylamide hybrids as multi-target directed ligands against Alzheimer's disease and mechanistic insights into their binding with acetylcholinesterase.
Yelamanda Rao K; Jeelan Basha S; Monika K; Naidu Gajula N; Sivakumar I; Kumar S; Vadde R; Aramati BMR; Subramanyam R; Damu AG
J Biomol Struct Dyn; 2023 Dec; 41(20):11148-11165. PubMed ID: 37098803
[TBL] [Abstract][Full Text] [Related]
7. Sulfonyl thioureas with a benzo[d]thiazole ring as dual acetylcholinesterase/butyrylcholinesterase and human monoamine oxidase A and B inhibitors: An in vitro and in silico study.
Dinh Thanh N; Son Hai D; Ngoc Toan V; Thi Kim Van H; Thi Kim Giang N; Minh Tri N
Arch Pharm (Weinheim); 2024 May; 357(5):e2300557. PubMed ID: 38321839
[TBL] [Abstract][Full Text] [Related]
8. Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults.
Samarelli F; Purgatorio R; Lopopolo G; Deruvo C; Catto M; Andresini M; Carrieri A; Nicolotti O; De Palma A; Miniero DV; de Candia M; Altomare CD
Eur J Med Chem; 2024 Apr; 270():116353. PubMed ID: 38579622
[TBL] [Abstract][Full Text] [Related]
9. Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer's disease.
Du H; Song J; Ma F; Gao H; Zhao X; Mao R; He X; Yan Y
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2281893. PubMed ID: 37965884
[TBL] [Abstract][Full Text] [Related]
10. Conjugates of amiridine and thiouracil derivatives as effective inhibitors of butyrylcholinesterase with the potential to block β-amyloid aggregation.
Khudina OG; Grishchenko MV; Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Shchegolkov EV; Borisevich SS; Burgart YV; Saloutin VI; Charushin VN
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300447. PubMed ID: 38072670
[TBL] [Abstract][Full Text] [Related]
11. Combining Chalcones with Donepezil to Inhibit Both Cholinesterases and Aβ Fibril Assembly.
Thamban Chandrika N; Fosso MY; Tsodikov OV; LeVine Iii H; Garneau-Tsodikova S
Molecules; 2019 Dec; 25(1):. PubMed ID: 31878304
[TBL] [Abstract][Full Text] [Related]
12. Combining Experimental and Computational Methods to Produce Conjugates of Anticholinesterase and Antioxidant Pharmacophores with Linker Chemistries Affecting Biological Activities Related to Treatment of Alzheimer's Disease.
Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Lushchekina SV; Astakhova TY; Timokhina EN; Serkov IV; Proshin AN; Soldatova YV; Poletaeva DA; Faingold II; Mumyatova VA; Terentiev AA; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257233
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, and computational studies of
Al-Rifai NM; Al-Khalileh NM; Zahra JA; El-Barghouthi MI; Darras FH
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2281264. PubMed ID: 37985494
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Quinolinone Hybrids as Dual Inhibitors of Acetylcholinesterase and Aβ Aggregation for Alzheimer's Disease Therapy.
Manzoor S; Gabr MT; Nafie MS; Raza MK; Khan A; Nayeem SM; Arafa RK; Hoda N
ACS Chem Neurosci; 2024 Feb; 15(3):539-559. PubMed ID: 38149821
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and molecular docking studies of 5-trifluoromethoxy-2-indolinones as cholinesterase dual inhibitors.
Soylu-Eter Ö; Özsoy N; Karalı N
Future Med Chem; 2024 Apr; 16(7):623-645. PubMed ID: 38470247
[No Abstract] [Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Ferulic Acid Template-Based Novel Multifunctional Ligands Targeting NLRP3 Inflammasome for the Management of Alzheimer's Disease.
Singh G; Shankar G; Panda SR; Kumar S; Rai S; Verma H; Kumar P; Nayak PK; Naidu VGM; Srikrishna S; Kumar S; Modi G
ACS Chem Neurosci; 2024 Apr; 15(7):1388-1414. PubMed ID: 38525886
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and neuroprotective activity of 3-aryl-3-azetidinyl acetic acid methyl ester derivatives.
Šachlevičiūtė U; Gonzalez G; Kvasnicová M; Štěpánková Š; Kleizienė N; Bieliauskas A; Zatloukal M; Strnad M; Sløk FA; Kvasnica M; Šačkus A; Žukauskaitė A
Arch Pharm (Weinheim); 2023 Dec; 356(12):e2300378. PubMed ID: 37797174
[TBL] [Abstract][Full Text] [Related]
18. Unveiling new thiazole-clubbed piperazine derivatives as multitarget anti-AD: Design, synthesis, and in silico studies.
Nasr EE; Tawfik SS; Massoud MAM; Mostafa AS
Arch Pharm (Weinheim); 2024 May; ():e2400044. PubMed ID: 38754070
[TBL] [Abstract][Full Text] [Related]
19. Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo.
Mugnaini C; Brizzi A; Paolino M; Scarselli E; Castelli R; de Candia M; Gambacorta N; Nicolotti O; Kostrzewa M; Kumar P; Mahmoud AM; Borgonetti V; Iannotta M; Morace A; Galeotti N; Maione S; Altomare CD; Ligresti A; Corelli F
ACS Chem Neurosci; 2024 Mar; 15(5):955-971. PubMed ID: 38372253
[TBL] [Abstract][Full Text] [Related]
20. Highly Potent and Selective Butyrylcholinesterase Inhibitors for Cognitive Improvement and Neuroprotection.
Li Q; Chen Y; Xing S; Liao Q; Xiong B; Wang Y; Lu W; He S; Feng F; Liu W; Chen Y; Sun H
J Med Chem; 2021 May; 64(10):6856-6876. PubMed ID: 33973470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
